Cohance Lifesciences Limited announced that India Ratings & Research has assigned a credit rating to its bank loan facilities. The rating assigned is IND AA/Stable/IND A1+ for bank loan facilities amounting to INR 6,850 million. The rating assignment was based on a letter received on December 3, 2025. This rating reflects India Ratings’ assessment of the company’s creditworthiness and stability.
New Credit Rating Assigned
India Ratings & Research has assigned a rating of IND AA/Stable/IND A1+ to Cohance Lifesciences Limited’s bank loan facilities. The total size of the issue is INR 6,850 million.
Details of Rated Facilities
The facilities that have been rated are bank loan facilities.
Breakdown of Facilities
The total facilities break-up includes Term Loans and Fund-based working capital limits from several banks:
- Citibank N.A.: Term Loan (INR 343.00 million)
- Axis Bank Limited: Term Loan (INR 833.00 million)
- IndusInd Bank Limited: Fund-based working capital limits (INR 550.00 million)
- State Bank of India: Fund-based working capital limits (INR 1300.00 million), Non-fund-based working capital limits (INR 270.00 million)
- HDFC Bank Limited: Fund-based working capital limits (INR 900.00 million)
- ICICI Bank: Fund-based working capital limits (INR 418.00 million)
- Hongkong Shanghai Banking Corporation: Fund-based working capital limits (INR 400.00 million)
- Bank of Bahrain and Kuwait: Fund-based working capital limits (INR 100.00 million)
- Citibank N.A.: Fund-based working capital limits (INR 250.00 million)
- Kotak Mahindra Bank: Fund-based working capital limits (INR 270.00 million)
- NA: Proposed Fund-based working capital limits (INR 66.00 million)
Source: BSE